https://www.selleckchem.com/pr....oducts/Triciribine.h
Groups were propensity score-matched at baseline to account for potential confounding. There were no statistically significant differences observed between the TNFi and non-TNFi treatment groups for outcomes assessed, except the incidence rate ratio for anaemia, which slightly favoured the TNFi group (19.04 per 100 person-years) versus the non-TNFi group (24.01 per 100 person-years, p=0.03). No potential effect modifiers were found to be statistically significant. The findings of no significant differences in outcomes between first-
Me gusta
Comentario
Compartir
